Malignant hyperthermia is caused by an inherited genetic mutation that makes skeletal muscle cells flood with calcium when exposed to certain anesthesia drugs. Between 1 in 5,000 and 1 in 100,000 general anesthesia procedures triggers an episode, with over half of all reactions occurring in children under 15. The condition is not something that develops over time. You’re born with the susceptibility, and it stays silent until the wrong drug is introduced.
The Genetic Root: A Faulty Calcium Channel
The primary cause in 50 to 70 percent of susceptible people is a mutation in the RYR1 gene. This gene provides the blueprint for a calcium channel embedded in your muscle cells. Under normal circumstances, this channel opens in a tightly controlled way during muscle contraction, releasing calcium from internal storage compartments into the cell, then pumping it back when contraction is complete. In people with an RYR1 mutation, the channel is essentially hyperactive. It releases more calcium than it should, and in some cases it “leaks” calcium even at rest.
A much smaller fraction of cases, roughly 1 percent, involves a mutation in a different gene called CACNA1S, which codes for a partner protein that physically touches the RYR1 channel and tells it when to open. A third gene, STAC3, has also been linked to susceptibility, though it accounts for an even smaller share. In about 30 to 50 percent of susceptible individuals, the specific genetic cause hasn’t been identified yet, which means other genes likely play a role.
The condition follows an autosomal dominant inheritance pattern, meaning you only need one copy of the mutated gene (from one parent) to be susceptible. But the expression is variable. Two people in the same family can carry the identical mutation and respond very differently to anesthesia. One might have a severe crisis during their first surgery, while another might undergo multiple procedures before anything goes wrong.
What Triggers an Episode
The genetic susceptibility alone doesn’t cause a crisis. It takes a triggering drug to set one off. The two categories of triggers are halogenated volatile anesthetics (gases like halothane, sevoflurane, desflurane, and isoflurane) and the depolarizing muscle relaxant succinylcholine. These are among the most commonly used drugs in general anesthesia, which is why malignant hyperthermia remains a persistent surgical risk.
Succinylcholine-induced jaw muscle rigidity occurs in about 1 in 100 children when the drug is combined with halothane. That rigidity is sometimes the first warning sign. In rarer cases, stressors like extreme heat or vigorous exercise have been reported as triggers in genetically susceptible people, though anesthesia drugs are by far the most common cause.
What Happens Inside the Body During a Crisis
When a triggering agent hits muscle cells with a defective calcium channel, the channel opens wide and stays open. Calcium pours out of its storage compartment and accumulates in the cell. This sets off a chain reaction. The muscle cell interprets all that calcium as a signal to contract, so muscles lock up and won’t relax. The cell’s energy system goes into overdrive trying to pump the calcium back where it belongs, burning through enormous amounts of ATP (the cell’s energy currency) and generating intense heat in the process.
As the cell’s energy reserves deplete, it can no longer maintain itself. Carbon dioxide production spikes. Oxygen consumption soars. Acid builds up in the blood. Body temperature can rise rapidly, sometimes climbing several degrees in minutes. If the process continues unchecked, muscle fibers begin breaking down, releasing their contents into the bloodstream. This breakdown can damage the kidneys and disrupt heart rhythm. Before effective treatment existed, the condition was frequently fatal.
Who Is Most at Risk
The mean age of reaction is 18.3 years, and children under 15 account for more than half of all episodes. This skew toward younger patients partly reflects how often children receive the specific drugs that trigger reactions, particularly succinylcholine and halothane. Males are affected more frequently than females, though the genetic susceptibility is equal across sexes.
Because a person can undergo anesthesia multiple times without incident before having a reaction (thanks to variable penetrance), a history of uneventful surgeries doesn’t rule out susceptibility. Family history is the most important clue. If a blood relative has had a confirmed episode or tested positive, you should assume you may be susceptible until proven otherwise.
How Susceptibility Is Diagnosed
The standard diagnostic test is the caffeine-halothane contracture test, which requires a small piece of living muscle tissue taken during a biopsy. The tissue is exposed to halothane and caffeine in a lab, and the force of its contraction is measured. This test has a sensitivity of 97 percent, meaning it catches nearly all susceptible individuals, and a specificity of 78 percent, meaning about 1 in 5 positive results may be a false alarm. Because the test requires surgery and is only available at specialized centers, it’s reserved for people with a strong clinical reason to be tested.
Genetic testing offers a less invasive alternative. A blood sample is screened for known mutations in RYR1, CACNA1S, and STAC3. The limitation is that a positive result confirms susceptibility, but a negative result doesn’t rule it out, since not all causative mutations have been identified. For families with a known mutation, genetic testing is a straightforward way to screen relatives.
Safe Alternatives for Susceptible Patients
If you know or suspect you’re susceptible, general anesthesia is still possible. The Malignant Hyperthermia Association of the United States maintains a list of safe agents. All local anesthetics are safe. Intravenous anesthetics like propofol, ketamine, and etomidate are safe. Nitrous oxide is safe. All opioid painkillers used in surgical settings, including fentanyl, morphine, and remifentanil, are safe. Non-depolarizing muscle relaxants like rocuronium and vecuronium are safe.
The only drugs that must be avoided are the halogenated volatile anesthetics and succinylcholine. Modern anesthesia teams can deliver a complete, effective anesthetic using entirely non-triggering agents. The key is knowing your status before you go under, which is why sharing any family history of anesthesia complications with your surgical team matters more than almost any other piece of your medical history.
Treatment During an Acute Episode
When an episode is recognized in the operating room, the triggering agent is immediately discontinued and a drug called dantrolene is given intravenously. Dantrolene works by directly blocking calcium release from the faulty channel, essentially shutting down the runaway process at its source. The initial dose is 2.5 mg per kilogram of body weight, and additional doses can be given up to 10 mg per kilogram if the crisis is severe. In larger patients experiencing a full-blown episode, the upper end of that range is sometimes necessary.
Since dantrolene became the standard treatment, survival rates have improved dramatically. Early recognition is critical: a sudden, unexplained rise in exhaled carbon dioxide during surgery is typically the earliest measurable sign, often appearing before temperature begins climbing. Jaw muscle rigidity after succinylcholine is another early red flag. The faster the anesthesia team identifies these signals and starts treatment, the better the outcome.